Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CLIFFORD L DEAL

NPI
1164484283
CMS profile
7213
Location
RICHMOND, VA

General Payments · PY2018–2024

$13,327.54

  • Reported across 80 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$951.61

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $533.79 13
Long term medical supply or device loan $407.86 2
Travel and Lodging $9.96 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $204.54 7
PY2019 $295.15 5
PY2020 $6,627.44 9
PY2021 $1,688.61 10
PY2022 $1,096.03 18
PY2023 $2,464.16 15
PY2024 $951.61 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $34.33 09/03/2024 Food and Beverage Undisputed 01/23/2026 1105480733 CMS
Boston Scientific Corporation $14.69 10/22/2024 Food and Beverage Undisputed 01/23/2026 1092345416 CMS
Davol Inc. $24.37 01/04/2024 Food and Beverage Undisputed 01/23/2026 1127667076 CMS
DePuy Synthes Sales Inc. $30.40 11/14/2024 Food and Beverage Undisputed 01/23/2026 1077899742 CMS
Endomagnetics Ltd $153.45 04/10/2024 Food and Beverage Undisputed 01/23/2026 1144310048 CMS
Endomagnetics Ltd $125.95 04/11/2024 Food and Beverage Undisputed 01/23/2026 1144309564 CMS
Endomagnetics Ltd $9.96 04/11/2024 Travel and Lodging Undisputed 01/23/2026 1144309788 CMS
Integra LifeSciences Corporation $17.06 03/21/2024 Food and Beverage Undisputed 01/23/2026 1140087396 CMS
Integra LifeSciences Corporation $261.18 06/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1140087384 CMS
Integra LifeSciences Corporation $146.68 08/20/2024 Long term medical supply or device loan Undisputed 01/23/2026 1140087390 CMS
Merck Sharp & Dohme LLC $15.28 03/12/2024 Food and Beverage Undisputed 01/23/2026 1141675459 CMS
Pacira Pharmaceuticals Incorporated $23.71 02/27/2024 Food and Beverage Undisputed 01/23/2026 1151242735 CMS
Stryker Corporation $34.44 05/16/2024 Food and Beverage Undisputed 01/23/2026 1119811437 CMS
Stryker Corporation $13.07 05/17/2024 Food and Beverage Undisputed 01/23/2026 1119811439 CMS
TELA Bio, Inc. $28.79 05/28/2024 Food and Beverage Undisputed 01/23/2026 1154189176 CMS
VERTEX PHARMACEUTICALS INCORPORATED $18.25 11/21/2024 Food and Beverage Undisputed 01/23/2026 1105910374 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.